[go: up one dir, main page]

DE69933579D1 - Serum-freies medium für chondrozyt-ähnliche zellen - Google Patents

Serum-freies medium für chondrozyt-ähnliche zellen

Info

Publication number
DE69933579D1
DE69933579D1 DE69933579T DE69933579T DE69933579D1 DE 69933579 D1 DE69933579 D1 DE 69933579D1 DE 69933579 T DE69933579 T DE 69933579T DE 69933579 T DE69933579 T DE 69933579T DE 69933579 D1 DE69933579 D1 DE 69933579D1
Authority
DE
Germany
Prior art keywords
serum
free medium
chondrocytes
chondrocyte
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69933579T
Other languages
English (en)
Inventor
Ranieri Cancedda
Beatrice Dozin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per la Ricerca Sul Cancro
Consorzio per la Gestione del Centro di Biotecnologia Avanzata
Original Assignee
Istituto Nazionale per la Ricerca Sul Cancro
Consorzio per la Gestione del Centro di Biotecnologia Avanzata
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Nazionale per la Ricerca Sul Cancro, Consorzio per la Gestione del Centro di Biotecnologia Avanzata filed Critical Istituto Nazionale per la Ricerca Sul Cancro
Application granted granted Critical
Publication of DE69933579D1 publication Critical patent/DE69933579D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69933579T 1998-11-09 1999-11-08 Serum-freies medium für chondrozyt-ähnliche zellen Expired - Fee Related DE69933579D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10764698P 1998-11-09 1998-11-09
PCT/EP1999/008482 WO2000027996A1 (en) 1998-11-09 1999-11-08 Serum free medium for chondrocyte-like cells

Publications (1)

Publication Number Publication Date
DE69933579D1 true DE69933579D1 (de) 2006-11-23

Family

ID=22317692

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933579T Expired - Fee Related DE69933579D1 (de) 1998-11-09 1999-11-08 Serum-freies medium für chondrozyt-ähnliche zellen

Country Status (10)

Country Link
US (2) US6617159B1 (de)
EP (1) EP1131407B1 (de)
JP (1) JP2002529071A (de)
AT (1) ATE342348T1 (de)
AU (1) AU758073B2 (de)
CA (1) CA2348687A1 (de)
DE (1) DE69933579D1 (de)
IL (2) IL142914A0 (de)
RU (1) RU2272839C2 (de)
WO (1) WO2000027996A1 (de)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2217031T3 (es) * 1999-12-28 2004-11-01 Iso Tis N.V. Medio de cultivo de celulas que contiene factores de crecimiento y l-glutamina.
JP2004531256A (ja) 2001-04-24 2004-10-14 バクシュ，ドロレス 前駆細胞集団、その増殖、及びそれからの非造血細胞種及び組織の成長
FR2828401B1 (fr) * 2001-08-10 2003-11-07 Oreal Composition cosmetique ou dermatologique comprenant une association entre l'igf1 et/ou un compose mimetique de l'igf1, et l'acide ascorbique et/ou au moins l'un de ses derives
JP2003052360A (ja) * 2001-08-20 2003-02-25 Japan Science & Technology Corp 基底膜細胞外基質を用いた間葉系幹細胞の培養方法
EP1463800A4 (de) 2001-12-07 2006-04-26 Geron Corp Von menschlichen embryonalen stammzellen abgeleitete chondrozyten-vorläuferzellen
US20070141036A1 (en) * 2002-01-09 2007-06-21 Alberto Gorrochategui Barrueta Composition and procedure for tissue creation, regeneration and repair by a cell-bearing biological implant enriched with platelet concentrate and supplements
US7169610B2 (en) 2002-01-25 2007-01-30 Genzyme Corporation Serum-free media for chondrocytes and methods of use thereof
US7741116B2 (en) * 2002-03-06 2010-06-22 University Of Cincinnati Surgical device for skin therapy or testing
AU2003220966A1 (en) * 2002-04-03 2003-10-13 Naohide Yamashita Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
EP3175858B1 (de) * 2002-05-22 2019-08-21 Matsutani Chemical Industry Co., Ltd. Therapeutische verwendung von d-allose für die behandlung von leberkrebs oder hautkrebs
DE10311620A1 (de) * 2003-03-17 2004-10-07 Biotissue Technologies Gmbh Knorpelzell-Kulturmedium und Verwendung desselben
AU2003903896A0 (en) 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
US20050233446A1 (en) * 2003-12-31 2005-10-20 Parsons Xuejun H Defined media for stem cell culture
EP1725656B1 (de) * 2004-03-05 2013-10-02 John E. Davies Serumfreies suspensionskultursystem fürmesenchym-vorläuferzellen
WO2005099758A2 (en) * 2004-04-17 2005-10-27 The Board Of Trustees The Leland Standford Junior University Injectable bioartificial tissue matrix
US20050265980A1 (en) * 2004-05-14 2005-12-01 Becton, Dickinson And Company Cell culture environments for the serum-free expansion of mesenchymal stem cells
WO2006004149A1 (ja) * 2004-07-06 2006-01-12 Kyowa Hakko Kogyo Co., Ltd. 神経細胞の製造方法
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
JP4646600B2 (ja) * 2004-11-02 2011-03-09 オリンパス株式会社 間葉系幹細胞の培養方法
JP2006136281A (ja) * 2004-11-15 2006-06-01 Olympus Corp 培地および間葉系幹細胞の培養方法
JPWO2006054448A1 (ja) 2004-11-19 2008-05-29 株式会社ジェイ・エム・エス 細胞培養用ヒト血清
EP2210937A1 (de) 2005-05-09 2010-07-28 Olympus Corporation Kulturverfahren für mesenchymale Stammzelle und Verfahren zur Herstellung von Trägermaterial für biologisches Gewebe
US20090169523A1 (en) 2005-06-13 2009-07-02 Catherine Verfaillie Hsc self-renewal
JP5001155B2 (ja) * 2005-08-23 2012-08-15 公立大学法人横浜市立大学 ラミニン５を利用した間葉系幹細胞の培養技術
JP4921083B2 (ja) * 2005-09-13 2012-04-18 タカラバイオ株式会社 レトロウィルス産生用無血清培地
WO2007044418A2 (en) * 2005-10-06 2007-04-19 Moscatello David K Cell culture media, kits and methods of use
DE102005054577A1 (de) * 2005-11-16 2007-05-24 Cognis Ip Management Gmbh Verwendung von Estern ungesättigter, physiologisch aktiver Fettsäuren als Nährmedien für Zellkulturen
KR101107835B1 (ko) 2006-01-13 2012-02-09 가부시키가이샤 투셀 동물 세포의 무혈청 배양에 사용하기 위한 배양 배지 첨가물, 키트 및 이의 용도
ITTO20060282A1 (it) * 2006-04-14 2007-10-15 Univ Degli Studi Torino Mezzo di coltura e composizione farmaceutica per la rigenerazione del tessuto cartilagineo relativo procedimento relativi usi e prodotti
MX2008016429A (es) * 2006-06-20 2009-03-20 Genzyme Corp Medios de suero y sus usos para expansion de condrocitos.
EP1900810A1 (de) * 2006-09-15 2008-03-19 Celogos Verfahren zur Zellextraktion und Zellselektion
JP2008099662A (ja) 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法
EP1972685B1 (de) * 2007-03-20 2015-09-02 Université Paris Descartes Kulturmedium für Zahnfleischfibroblasten
US8114668B2 (en) 2007-05-14 2012-02-14 Cardiac Pacemakers, Inc. Composition for cold storage of stem cells
ITMI20071421A1 (it) * 2007-07-16 2009-01-17 Fond Irccs Istituto Di Ricove Coltura per espandere cellule staminali ex-vivo
WO2009030092A1 (en) * 2007-09-05 2009-03-12 Institute Of Basic Medical Sciences Chinese Academy Of Medical Sciences Culture medium and method for in vitro culturing human adult primary mesenchymal stem cells on a large scale, primary mesenchymal stem cells obtained by the method, the uses thereof
US20110111492A1 (en) 2008-01-18 2011-05-12 Regents Of The University Of Minnesota Stem Cell Aggregates and Methods for Making and Using
US20100015710A1 (en) * 2008-04-25 2010-01-21 Sunghoon Jung Methods and Compositions for Isolating, Maintaining and Serially Expanding Human Mesenchymal Stem Cells
CN102159703B (zh) * 2008-06-30 2015-11-25 森托科尔奥索生物科技公司 多能干细胞的分化
EP2351831B1 (de) * 2008-11-11 2017-06-14 Hiroshima University Zusatzstoff zur differenzierungsinduktion eines kulturmediums und verwendung davon
US20110020292A1 (en) 2009-07-21 2011-01-27 Abt Holding Company Use of Stem Cells to Reduce Leukocyte Extravasation
KR20180014224A (ko) 2009-07-21 2018-02-07 에이비티 홀딩 컴퍼니 백혈구 혈관외유출을 감소시키기 위한 줄기 세포의 용도
SG10201403202XA (en) * 2009-07-23 2014-08-28 Agency Science Tech & Res Pre-natal mesenchymal stem cells
US9018010B2 (en) * 2009-11-12 2015-04-28 Technion Research & Development Foundation Limited Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
AU2011220721B2 (en) 2010-02-25 2015-02-05 Case Western Reserve University Modulation of macrophage activation
SG183498A1 (en) 2010-02-25 2012-09-27 Abt Holding Co Modulation of angiogenesis
EP2545928B1 (de) 2010-03-10 2016-07-20 Two Cells Co., Ltd Zellpräparat mit mesenchymalen stammzellen und herstellungsverfahren dafür
CN102933704A (zh) 2010-04-08 2013-02-13 爱丁堡大学管理处 软骨祖细胞、用于细胞衍生的方案和其用途
WO2011143415A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy
US9090878B2 (en) 2010-06-17 2015-07-28 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
SG10201506664TA (en) 2010-08-24 2015-10-29 Univ Minnesota Non-static suspension culture of cell aggregates
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US9388388B2 (en) 2011-01-31 2016-07-12 Katholieke Universiteit Leuven Methods for making cells with an extra-embryonic endodermal precursor phenotype
JP6182135B2 (ja) 2011-06-06 2017-08-16 レゲネシス ベーフェーベーアー 中空繊維バイオリアクター中での幹細胞の増幅
RU2461623C1 (ru) * 2011-06-20 2012-09-20 Борис Карпович Гаврилюк Способ выращивания культур хрящевых клеток
WO2013019661A1 (en) * 2011-07-29 2013-02-07 Cellular Dynamics International, Inc. Metabolic maturation in stem cell-derived tissue cells
JP2014526887A (ja) 2011-08-01 2014-10-09 アルナイラム ファーマシューティカルズ， インコーポレイテッド 造血幹細胞移植の成功率を改善する方法
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
US9321995B2 (en) * 2012-12-20 2016-04-26 Suzhou Biowisetech Co., Ltd. Stem cell culture medium and its applications as well as a stem cell culture method
WO2014146057A2 (en) * 2013-03-15 2014-09-18 Cmr Technologies, Llc Mesenchymal stem cells
CA2909267C (en) 2013-04-12 2022-10-25 Saverio LA FRANCESCA Improving organs for transplantation
DK2992088T3 (da) 2013-04-30 2019-11-11 Univ Leuven Kath Celleterapi for myelodysplastiske syndromer
JP6512759B2 (ja) * 2013-08-19 2019-05-15 国立研究開発法人国立循環器病研究センター 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤
ES2984009T3 (es) * 2013-11-04 2024-10-28 Isopogen Pty Ltd Método de cultivo celular
EP3068866B1 (de) 2013-11-16 2018-04-25 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
CN103805562B (zh) * 2014-01-13 2015-08-05 章毅 培养胎盘间充质干细胞的无血清培养基
EP3122866B1 (de) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passives ersetzen von medien
US9433629B2 (en) 2014-05-23 2016-09-06 Juan Paz Garcia Formulation for regeneration of bone, cartilage, teeth, and periodontium and treatment of tumors and cysts
KR102451667B1 (ko) * 2014-05-23 2022-10-06 후안 파스 가르시아 골, 연골, 치아 및 치주의 재생 및 종양 및 낭포의 치료를 위한 제형
US9669074B2 (en) * 2014-05-23 2017-06-06 Juan Paz Garcia Formulation for regeneration of bone, cartilage, teeth, and periodontium and treatment of tumors and cysts
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
JP6533234B2 (ja) * 2014-11-14 2019-06-19 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
AU2016227607B2 (en) * 2015-03-04 2021-09-30 Mesoblast International Sarl Cell culture method for mesenchymal stem cells
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
SG10201914102UA (en) 2016-01-21 2020-03-30 Abt Holding Co Stem cells for wound healing
EP3464565A4 (de) 2016-05-25 2020-01-01 Terumo BCT, Inc. Zellexpansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
SG11201900058YA (en) * 2016-07-04 2019-02-27 Agency Science Tech & Res Method of generating mesenchymal stem cells and uses thereof
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
KR20200064131A (ko) 2017-10-13 2020-06-05 베링거 인겔하임 인터내셔날 게엠베하 관류 배지
JP7372518B2 (ja) * 2019-06-27 2023-11-01 国立大学法人山口大学 骨髄由来間葉系幹細胞の培養方法
EP4100432B1 (de) * 2020-02-03 2025-03-19 Mosa Meat B.V. Serumfreies medium zur kultivierung einer vorläuferzelle
EP4314244A1 (de) 2021-03-23 2024-02-07 Terumo BCT, Inc. Zellerfassung und -erweiterung
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
WO2025018336A1 (ja) * 2023-07-20 2025-01-23 学校法人近畿大学 無血清培地
WO2025037108A2 (en) 2023-08-15 2025-02-20 Board Of Trustees Of The Leland Stanford Junior University Modified thrombopoietin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
AU6125396A (en) 1995-06-07 1996-12-30 Novartis Ag Serum-free media for primitive hematopoietic cells and metho ds of use thereof
WO1997033978A1 (en) * 1996-03-12 1997-09-18 Life Technologies, Inc. Hematopoietic cell culture nutrient supplement
CA2261292C (en) * 1996-07-25 2008-09-30 Genzyme Corporation Chondrocyte media formulations and culture procedures
EP0948255B1 (de) * 1996-12-06 2005-10-19 Osiris Therapeutics, Inc. Verbesserte chondrogene differenzierung von menschlichen mesenchym-stammzellen

Also Published As

Publication number Publication date
EP1131407A1 (de) 2001-09-12
US20050090002A1 (en) 2005-04-28
AU1380400A (en) 2000-05-29
ATE342348T1 (de) 2006-11-15
CA2348687A1 (en) 2000-05-18
US6617159B1 (en) 2003-09-09
US7109032B2 (en) 2006-09-19
RU2272839C2 (ru) 2006-03-27
EP1131407B1 (de) 2006-10-11
JP2002529071A (ja) 2002-09-10
IL142914A0 (en) 2002-04-21
AU758073B2 (en) 2003-03-13
WO2000027996A1 (en) 2000-05-18
IL142914A (en) 2006-07-05

Similar Documents

Publication Publication Date Title
DE69933579D1 (de) Serum-freies medium für chondrozyt-ähnliche zellen
RU2001116126A (ru) Бессывороточная среда для хондроцитоподобных клеток
WO1998059035A3 (en) Serum-free cell growth medium
FR2726003B1 (fr) Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
DK1918364T3 (da) Fremgangsmåde til rekloning af produktionsceller
GB2432846A (en) Medium and culture of embryonic stem cells
WO2002072762A3 (en) Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
WO2006047380A3 (en) Method and media for single cell serum-fee culture of cho cells
CA2402299A1 (en) Serum free cultivation of primate embryonic stem cells
WO2003064598A3 (en) Serum-free media for chondrocytes and methods of use thereof
JP2003525625A5 (de)
WO2003014313A3 (en) Alternative compositions and methods for the culture of stem cells
ATE399855T1 (de) Tierzellkulturmedium mit pflanzlichen nährstoffen
JPH0387174A (ja) 細胞培養基
WO2000017321A3 (en) Use of growth factors and hormones for expansion of mammalian cells and tissue engineering
JP2013510567A5 (de)
WO1998004681A3 (en) Chondrocyte media formulations and culture procedures
EP0953354A4 (de) Hämatopoietische stammzellen proliferierende wirkstoffe
NO20033396D0 (no) Forbedret in vitro fremgangsmåte for kultivering av mammale celler for autolog celle implantasjon/transplantasjon fremgangsmåter
WO2004087885A3 (en) Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
WO2006045064A3 (en) Cultured hematopoietic stem cells and method for expansion and analysis thereof
DE69029856D1 (de) Verfahren, zubereitungen und anordnungen für zellzucht
NZ502712A (en) Medium and method for long term culturing of avian primordial germ cells (PGC) in a tissue culture comprising growth factors
CN105624102A (zh) 利用人的尿液细胞构建软骨组织的方法
CA3168116A1 (en) Utilization of fgf activators in culture media

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee